stepholidine/dyskinesias

Lyen an sove nan clipboard la

AtikEsè klinikPatant

Chwazi kalite sòt

6 rezilta yo

[Clinical study on the treatment of dyskinesia by L-stepholidine].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

134 cases of dyskinesia caused by various CNS diseases were treated with a new type of DA blocker L-Stepholidine (1-SPD). Good response was obtained in 72% (29/40) of L-dopa induced abnormal involuntary movements in Parkinson disease, 79% (34/43) of Tourette syndrome, and 65% (15/23) of tardive

L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia (LID) remains a challenge in Parkinson's disease (PD) drug therapy. In the present study, we examined the effect of L-stepholidine (L-SPD), a known dual dopamine receptor agent, on LID in 6-hydroxydopamine (6-OHDA)-lesioned PD rat model. Daily

[A controlled study on the treatment of tardive dyskinesia using 1-stepholidine].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Recent developments in studies of l-stepholidine and its analogs: chemistry, pharmacology and clinical implications.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Tetrahydroprotoberberines (THPBs) represent a series of compounds extracted from the Chinese herb Corydalis ambigua and various species of Stephania. THPBs, dependent on the presence of hydroxyl groups in its structure, are divided into three types: nonhydroxyl-THPBs, monohydroxyl-THPBs and

Miscellaneous treatments for neuroleptic-induced tardive dyskinesia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Tardive dyskinesia (TD) is a disabling movement disorder associated with the prolonged use of neuroleptic medication. This review, one in a series examining the treatment of tardive dyskinesia, will cover miscellaneous treatments not covered elsewhere. OBJECTIVE The primary objective of

Miscellaneous treatments for neuroleptic-induced tardive dyskinesia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Tardive dyskinesia is a disabling movement disorder associated with the prolonged use of neuroleptic medication. This review, one in a series examining the treatment of tardive dyskinesia, will cover miscellaneous treatments not covered elsewhere. OBJECTIVE To determine whether the

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye